Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
HCAT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.49 - $9.24
Previous CloseN/A
Volume315.36K
Average Volume (3M)525.65K
Market Cap
$262.40M
Enterprise Value$702.72M
Total Cash (Recent Filing)$341.97M
Total Debt (Recent Filing)$251.07M
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Jul 31, 2025EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding69,601,234
10 Day Avg. Volume506,381
30 Day Avg. Volume525,653
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.34
Price to Sales (P/S)0.00
P/FCF Ratio-10.84
Enterprise Value/Market Cap2.68
Enterprise Value/Revenue0.58
Enterprise Value/Gross Profit5.39
Enterprise Value/Ebitda-6.42
Forecast
1Y Price Target
$8.13Price Target Upside117.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Health Catalyst News
PremiumCompany Announcements
Health Catalyst’s Earnings Call Highlights Strong Q1 2025 Performance
PremiumCompany Announcements
Health Catalyst Reports Strong Q1 2025 ResultsBulls Say, Bears Say
Bulls Say
Client GrowthThe selling season is progressing well with expectations to add more platform clients, indicating growth potential.
Financial PerformanceHealth Catalyst reported revenue and adjusted EBITDA that exceeded consensus estimates, showing strong financial performance.
Platform InnovationThe new Ignite platform looks to be an attractive purchase with its lower price point and flexibility that shortens sales cycles and implementation times.
Bears Say
Implementation DelaysThere were delays in Professional Services revenue, particularly with Health Information Exchange clients.
Market ChallengesThe Budget Reconciliation Bill may reduce the total number of insured lives in the U.S., impacting Medicaid enrollment and causing challenges for HCAT.
Revenue Growth ConcernsHCAT's revenue growth has been slowing from 37%+ y/y in 2018 and 2019 to just 4% y/y growth in 2024, raising concerns about the company's growth prospects.
Ownership Overview
4.38% Insiders
20.02% Mutual Funds
38.07% Other Institutional Investors
26.00% Public Companies and Individual Investors
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $3.49 and its highest was $9.24 in the past 12 months.
What is Health Catalyst’s market cap?
Health Catalyst’s market cap is $262.40M.
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Jul 31, 2025 which is in 33 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on May 07, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.003 by $0.013.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is 0.04.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 69,601,234 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.003. Following the earnings report the stock price went up 5.29%.
Which hedge fund is a major shareholder of Health Catalyst?
Currently, no hedge funds are holding shares in HCAT
Health Catalyst Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.13 (117.38% Upside)
$8.13 (117.38% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 342.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 3.4%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.60%
12-Months-Change
Fundamentals
Return on Equity
-19.80%
Trailing 12-Months
Asset Growth
28.26%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
HCAT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a positive outlook with strong financial performance and successful Ignite platform adoption. However, there were challenges in Professional Services revenue and macroeconomic uncertainties that could affect future performance.Read More>HCAT Stock 12 Month Forecast
Average Price Target
$8.13
▲(117.38%Upside)